Filter
198
Filtered Results: 198
Text search:
monkeypox
Featured
Recommendations
26
New Publications
29
Language
Document type
Guidelines
42
No document type
40
Studies & Reports
34
Fact sheets
20
Situation Updates
16
Strategic & Response Plan
11
Resource Platforms
10
Online Courses
8
Infographics
6
Training Material
5
Manuals
3
Videos
3
Countries / Regions
Congo, Democratic Republic of
28
Africa
11
Nigeria
10
Global
6
Central African Republic
5
Germany
4
East and Southern Africa
4
Liberia
4
Mozambique
3
Latin America and the Carribbean
3
West and Central Africa
3
Ukraine
2
Togo
2
Western and Central Europe
2
South Africa
2
Angola
2
Lesotho
1
Ghana
1
Sierra Leone
1
Cameroon
1
Zimbabwe
1
United Kingdom
1
Brazil
1
Namibia
1
Mali
1
Chad
1
India
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
62
Countries
49
Key Resources
9
Public Health
4
Women & Child Health
4
Capacity Building
2
Pharmacy & Technologies
2
Toolboxes
Rapid Response
121
COVID-19
8
2.0 Rapid Response
7
Planetary Health
6
Caregiver
5
HIV
3
Ebola & Marburg
3
Conflict
3
TB
2
Health Financing Toolbox
2
Mental Health
1
Pharmacy
1
Polio
1
Global Health Education
1
AMR
1
Hinweise zur Therapie von Affenpocken
recommended
Therapiehinweise des STAKOB unter Mitwirkung von BfArM, DGI, DGPI, DTG, PEI und Pocken Konsiliarlabor RKI - ZBS 1
Seit Mai 2022 treten in Europa und auch in Deutschland Fälle von Affenpocken auf. Die Betroffenen erkranken in der Regel nicht schwer. Aktuelle Informationen über Ansteckung, Symptome, Schutz und Impfung gibt es hier.
Informationsplattform rund um Affenpocken
Aufgrund einer nicht auszuschließenden Übertragbarkeit der Affenpocken bereits in der Prodromalphase mit milden und sehr unspezifischen Symptomen ist
die Quarantäne für Kontaktpersonen mit hohem Übertragungsrisiko einschließlich der Haushaltsmitglieder geboten. Diese Empfehlung wird angepasst...
Fiche d'information
This interim operational guide outlines infection prevention, control, and water, sanitation, and hygiene measures for home care and isolation of mpox in resource-limited settings. It focuses on practical strategies to manage and prevent the spread of the virus when persons with mpox are isolated at...
On August 13, 2024, the Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS). The following day, the WHO declared it a Public Health Emergency of International Concern (PHEIC). A coordinated, continent-wide response is essential, co-led by the African Union...
The rapid assessment tool (RAT) is meant to assess health facilities within mpox-affected areas that have at least one inpatient bed. Depending on time and resources available, certain facilities may be prioritized during an mpox outbreak. The RAT evaluates 16 infection prevention and control (IPC) ...
Flyer German
Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People ...
Mpox Molecular Diagnostic Tests(RT-PCR)
recommended
March 2025. Access to appropriate, quality-assured diagnostics remains a challenge. There is limited information on key characteristics of available test kits, including their performance, reliability, and ability to detect relevant Mpox clades. Additionally, the lack of multiplex diagnostic tools c...
This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.
This document is for public health specialists, health emergency responders, clinicians, health facility managers, health and care workers and IPC practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, dental practices, infecti...
In conclusion, the current evidence does not support the use of mpox antigen RDTs in the field. More data are expected from independent evaluations conducted by Africa CDC, FIND or other organizations
